Melatonin inhibits maneb-induced aggregation of alpha-synuclein in rat pheochromocytoma cells - PubMed (original) (raw)
Melatonin inhibits maneb-induced aggregation of alpha-synuclein in rat pheochromocytoma cells
Masami Ishido. J Pineal Res. 2007 Mar.
Abstract
Melatonin, a secretory product of the pineal gland, is involved in the regulation of circadian and seasonal rhythms, in oncostasis, and in inducing osteoblast differentiation. Furthermore, melatonin is a scavenger of a number of reactive oxygen and reactive nitrogen species both in vitro and in vivo. In this study, the antioxidant nature of melatonin was shown to prevent cultured neural cells from apoptosis induced by endocrine-disrupting chemical, maneb. The neurotoxicity of the fungicide, maneb (1 microg/mL), on the PC12 cells was elicited through apoptotic cell death, concomitant with aggregation of alpha-synuclein, a feature of Parkinson's disease. Activation of caspase-3/7 was associated with this process. A fluorescence rationing technique using a mitochondrial dye revealed that maneb altered the mitochondrial membrane potential of the neural cells. However, melatonin (1 nm) largely prevented the neural cells from the neural toxicant by inhibition of both caspase-3/7 activation and disruption of the mitochondrial transmembrane potential. Furthermore, aggregation of alpha-synuclein by maneb was also inhibited by melatonin. Thus, melatonin prevents maneb-induced neurodegeneration at a nighttime physiological blood concentration, most likely by inhibiting the aggregation of alpha-synuclein as well as preventing mitochondrial dysfunction in PC 12 cells.
Similar articles
- Melatonin attenuates arsenite-induced apoptosis in rat brain: involvement of mitochondrial and endoplasmic reticulum pathways and aggregation of alpha-synuclein.
Lin AM, Fang SF, Chao PL, Yang CH. Lin AM, et al. J Pineal Res. 2007 Sep;43(2):163-71. doi: 10.1111/j.1600-079X.2007.00456.x. J Pineal Res. 2007. PMID: 17645694 - Rifampicin protects PC12 cells against MPP+-induced apoptosis and inhibits the expression of an alpha-Synuclein multimer.
Xu J, Wei C, Xu C, Bennett MC, Zhang G, Li F, Tao E. Xu J, et al. Brain Res. 2007 Mar 30;1139:220-5. doi: 10.1016/j.brainres.2006.12.074. Epub 2007 Jan 4. Brain Res. 2007. PMID: 17280646 - Melatonin inhibits amphetamine-induced increase in alpha-synuclein and decrease in phosphorylated tyrosine hydroxylase in SK-N-SH cells.
Klongpanichapak S, Phansuwan-Pujito P, Ebadi M, Govitrapong P. Klongpanichapak S, et al. Neurosci Lett. 2008 May 16;436(3):309-13. doi: 10.1016/j.neulet.2008.03.053. Epub 2008 Mar 25. Neurosci Lett. 2008. PMID: 18406059 - Paraquat and maneb induced neurotoxicity.
Thrash B, Uthayathas S, Karuppagounder SS, Suppiramaniam V, Dhanasekaran M. Thrash B, et al. Proc West Pharmacol Soc. 2007;50:31-42. Proc West Pharmacol Soc. 2007. PMID: 18605226 Review. - Controlling the mass action of alpha-synuclein in Parkinson's disease.
Kim C, Lee SJ. Kim C, et al. J Neurochem. 2008 Oct;107(2):303-16. doi: 10.1111/j.1471-4159.2008.05612.x. Epub 2008 Sep 2. J Neurochem. 2008. PMID: 18691382 Review.
Cited by
- Fluoxetine ameliorates behavioral and neuropathological deficits in a transgenic model mouse of α-synucleinopathy.
Ubhi K, Inglis C, Mante M, Patrick C, Adame A, Spencer B, Rockenstein E, May V, Winkler J, Masliah E. Ubhi K, et al. Exp Neurol. 2012 Apr;234(2):405-16. doi: 10.1016/j.expneurol.2012.01.008. Epub 2012 Jan 16. Exp Neurol. 2012. PMID: 22281106 Free PMC article. - Melatonin combats molecular terrorism at the mitochondrial level.
Reiter RJ, Paredes SD, Korkmaz A, Jou MJ, Tan DX. Reiter RJ, et al. Interdiscip Toxicol. 2008 Sep;1(2):137-49. doi: 10.2478/v10102-010-0030-2. Interdiscip Toxicol. 2008. PMID: 21218104 Free PMC article. - Activation of STAT3 by pituitary adenylate cyclase-activating polypeptide (PACAP) during PACAP-promoted neurite outgrowth of PC12 cells.
Ishido M. Ishido M. J Mol Neurosci. 2010 Nov;42(3):349-58. doi: 10.1007/s12031-010-9376-3. Epub 2010 May 5. J Mol Neurosci. 2010. PMID: 20443077 - Circadian rhythms, Neuroinflammation and Oxidative Stress in the Story of Parkinson's Disease.
Vallée A, Lecarpentier Y, Guillevin R, Vallée JN. Vallée A, et al. Cells. 2020 Jan 28;9(2):314. doi: 10.3390/cells9020314. Cells. 2020. PMID: 32012898 Free PMC article. Review. - Melatoninergic System in Parkinson's Disease: From Neuroprotection to the Management of Motor and Nonmotor Symptoms.
Mack JM, Schamne MG, Sampaio TB, Pértile RA, Fernandes PA, Markus RP, Prediger RD. Mack JM, et al. Oxid Med Cell Longev. 2016;2016:3472032. doi: 10.1155/2016/3472032. Epub 2016 Oct 18. Oxid Med Cell Longev. 2016. PMID: 27829983 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials